Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate to Severe Atopic Eczema”

Showing 20 of 0 results

Large-scale testing (Phase 3)Ended earlyNCT05387707
What this trial is testing

Study to Evaluate the Efficacy and Safety of Oral Difelikefalin as Adjunct Therapy to a Topical Corticosteroid for Moderate to Severe Pruritus in Subjects With Atopic Dermatitis

Who this might be right for
PruritusAtopic Dermatitis
Cara Therapeutics, Inc. 287
Testing effectiveness (Phase 2)Looking for participantsNCT07330934
What this trial is testing

Evaluate Efficacy and Safety of IBI356 in Participants With Moderate to Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Innovent Biologics (Suzhou) Co. Ltd. 403
Large-scale testing (Phase 3)Study completedNCT03002571
What this trial is testing

Efficacy and Safety of IDP-124 Lotion for the Treatment of Moderate to Severe Atopic Dermatitis in Pediatric and Adult Subjects (301)

Who this might be right for
Atopic Dermatitis
Bausch Health Americas, Inc. 338
Not applicableLooking for participantsNCT05391061
What this trial is testing

Learn About the Study Medicine (Called Cibinqo) in People With Atopic Dermatitis

Who this might be right for
Dermatitis, Atopic
Pfizer 1,100
Large-scale testing (Phase 3)Study completedNCT03989349
What this trial is testing

Efficacy & Safety of Nemolizumab in Subjects With Moderate-to-Severe Atopic Dermatitis

Who this might be right for
Moderate-to-Severe Atopic Dermatitis
Galderma R&D 787
Post-approval studies (Phase 4)Study completedNCT00689832
What this trial is testing

Protopic Ointment in Children Atopic Eczema

Who this might be right for
Dermatitis, Atopic
Astellas Pharma Inc 487
Testing effectiveness (Phase 2)Study completedNCT03676036
What this trial is testing

Efficacy and Steroid Sparing Potential Study of DGLA Cream in Patients With Moderate to Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
DS Biopharma 42
Testing effectiveness (Phase 2)Study completedNCT02683928
What this trial is testing

To Assess the Safety and Activity of GBR 830, Compared to Placebo, in Adults With Moderate-to-severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Ichnos Sciences SA 64
Large-scale testing (Phase 3)Study completedNCT03428100
What this trial is testing

A Long-term Study of Baricitinib (LY3009104) With Topical Corticosteroids in Adults With Moderate to Severe Atopic Dermatitis That Are Not Controlled With Cyclosporine or for Those Who Cannot Take Oral Cyclosporine Because it is Not Medically Advisable

Who this might be right for
Atopic Dermatitis
Eli Lilly and Company 463
Large-scale testing (Phase 3)Study completedNCT05916365
What this trial is testing

Long-term Safety and Efficacy of Lebrikizumab in Adult and Adolescent Participant With Moderate-to-Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Almirall, S.A. 174
Large-scale testing (Phase 3)Study completedNCT03131648
What this trial is testing

Tralokinumab Monotherapy for Moderate to Severe Atopic Dermatitis - ECZTRA 1 (ECZema TRAlokinumab Trial no. 1)

Who this might be right for
Atopic Dermatitis
LEO Pharma 802
Early research (Phase 1)Not Yet RecruitingNCT07746817
What this trial is testing

BYN-001 in Healthy Adults and in Adults With Moderate to Severe Atopic Dermatitis

Who this might be right for
Atopic DermatitisHealthy Participants
Bionyra Pharma 56
Not applicableLooking for participantsNCT07544862
What this trial is testing

Stapokibart Injection in Patients With Atopic Dermatitis (AD)

Who this might be right for
Atopic Dermatitis (AD)
Chengdu Kangnuoxing Biopharma,Inc. 1,000
Large-scale testing (Phase 3)Study completedNCT05724199
What this trial is testing

A Study Assessing Rocatinlimab in Combination With Topical Corticosteroid and/or Topical Calcineurin Inhibitors in Adult Participants With Moderate-to-severe Atopic Dermatitis (AD)

Who this might be right for
Atopic Dermatitis
Amgen 746
Large-scale testing (Phase 3)Study completedNCT05372419
What this trial is testing

(LY3650150) Lebrikizumab to Assess the Safety and Efficacy of Adult and Adolescent Participants With Moderate-to-Severe Atopic Dermatitis and Skin of Color

Who this might be right for
Atopic Dermatitis
Eli Lilly and Company 90
Not applicableStudy completedNCT01569906
What this trial is testing

Narrowband UVB for Children With Moderate to Severe Atopic Eczema

Who this might be right for
Moderate to Severe Atopic Eczema
Royal Victoria Infirmary 58
Large-scale testing (Phase 3)Study completedNCT03346434
What this trial is testing

Safety, Pharmacokinetics and Efficacy of Dupilumab in Patients ≥6 Months to <6 Years With Moderate-to-Severe Atopic Dermatitis (Liberty AD PRESCHOOL)

Who this might be right for
Dermatitis, Atopic
Regeneron Pharmaceuticals 202
Testing effectiveness (Phase 2)Study completedNCT05018806
What this trial is testing

Proof of Concept Study of Rilzabrutinib in Adult Patients With Moderate-to-severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Sanofi 124
Testing effectiveness (Phase 2)Ended earlyNCT05984784
What this trial is testing

Evaluate the Safety, Pharmacokinetics, and Efficacy of IMG-007 in Adults With Atopic Dermatitis (AD)

Who this might be right for
Atopic DermatitisModerate-to-severe Atopic DermatitisAD
Inmagene LLC 13
Testing effectiveness (Phase 2)Study completedNCT03754309
What this trial is testing

KY1005 in Patients With Moderate to Severe Atopic Dermatitis

Who this might be right for
Dermatitis, Atopic
Kymab Limited 89
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation